$BFRI - taking off 1200 percent upside potential$BFRI - taking off 1200 percent upside potential The chart looks excellent
BFRI
BFRI high analyst ratingsBFRI Biofrontera is a biopharmaceutical company which commercializes pharmaceutical products for the treatment of dermatological conditions in the U.S.
Benchmark brokerage Initiated Coverage on BFRI with a Buy rating and a price of $11.00
Roth Capital brokerage Initiated Coverage on BFRI with a Buy rating and a price of $20.00
Looking forward to read your opinion about it.
BFRI 89.54% shortedAccording to MarketWatch, 89.54% of the float of Biofrontera Inc. (BFRI) is shorted.
Are you ready for a short squeeze?
How high will it go?
